Chabiotech Co.,Ltd. (KOSDAQ:085660)
11,030
+710 (6.88%)
May 14, 2025, 3:30 PM KST
Chabiotech Revenue
In the year 2024, Chabiotech had annual revenue of 1.05T KRW with 9.55% growth. Chabiotech had revenue of 275.98B in the quarter ending December 31, 2024, with 14.64% growth.
Revenue
1,045.05B
Revenue Growth
+9.55%
P/S Ratio
0.55
Revenue / Employee
3.58B
Employees
292
Market Cap
577.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,045.05B | 91.10B | 9.55% |
Dec 31, 2023 | 953.95B | 109.37B | 12.95% |
Dec 31, 2022 | 844.58B | 117.11B | 16.10% |
Dec 31, 2021 | 727.48B | 62.76B | 9.44% |
Dec 31, 2020 | 664.72B | 130.11B | 24.34% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
HLB Co., Ltd. | 68.13B |
SK Biopharmaceuticals | 547.60B |
PharmaResearch | 350.12B |
Peptron | 3.15B |